Optimal intervention time and risk of the activating blood and removing stasis method in acute cerebral hemorrhage patients: A randomized placebo-controlled trial
Discussion:
The study is expected to confirm the safety and effect of acute cerebral hemorrhage within 24 to 72 hours treated with the ABRS method and to determine the optimal time for intervention in this period.
Trial registration number:
ChiCTR1900022627
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Clinical Trial Source Type: research
More News: Brain | China Health | Clinical Trials | Disability | Hemorrhagic Stroke | Internal Medicine | National Institutes of Health (NIH) | Neurology | Stroke | Study